except that travelan is a really great product and is worth more than the current market cap on its own, which will really show when it receives FDA approval. Their cash balance is fine, they’ve received 5 million in funding from the US DoD that should last through to FDA approval.. I’m not predicting a cap raise any time soon. Maybe the sp will go down short term but LT holders will be rewarded. Dyor
C-diff results., page-10
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
